U.S. Construction Stock News

Sangamo Therapeutics (SGMO) investors are watching closely after the company received a 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price rule, alleviating immediate delisting concerns. The extension follows third quarter earnings that revealed sharply lower revenue and a wider net loss compared to last year. See our latest analysis for Sangamo Therapeutics. Sangamo Therapeutics has seen sustained downward pressure on its share price throughout the year, with...

The recent price decline of 11% in InspireMD, Inc.'s ( NASDAQ:NSPR ) stock may have disappointed insiders who bought...

Some AXT, Inc. ( NASDAQ:AXTI ) shareholders may be a little concerned to see that the Independent Director, David...

MBX Biosciences (MBX) shares have caught investors’ attention after a flurry of impactful company announcements. Recent positive Phase II trial results, analyst coverage, a large fundraising round, and board leadership changes are all shaping investor expectations. See our latest analysis for MBX Biosciences. MBX Biosciences’ recent string of breakthroughs has clearly energized the market, with the share price notching a remarkable 103% return in the past 90 days and a 56% gain over the last...

GoDaddy Inc.'s ( NYSE:GDDY ) stock was strong despite it releasing a soft earnings report last week. Our analysis...

With the business potentially at an important milestone, we thought we'd take a closer look at Prenetics Global...

BioLife Solutions (BLFS) shares have delivered a month of positive momentum, climbing nearly 3% and standing out among biotech peers. The stock’s moves come as investors keep a close watch on the company’s fundamentals and sector trends. See our latest analysis for BioLife Solutions. Momentum has been fairly steady for BioLife Solutions, with a 19% gain in its share price over the last 90 days. This hints at renewed optimism among investors. The company’s one-year total shareholder return...

Interparfums (IPAR) has had a turbulent ride over the past several months, with shares down 6% this month and a loss of 24% over the past 3 months. Investors are watching closely as the stock tries to find direction after recent declines. See our latest analysis for Interparfums. While Interparfums has been under some pressure lately, it is worth remembering that the bigger story goes beyond a single bad quarter. The 1-year total shareholder return of -28.5% confirms momentum has cooled...

The stock price didn't jump after GATX Corporation ( NYSE:GATX ) posted decent earnings last week. We did some digging...

Regency Centers Corporation recently reported higher third quarter and nine-month revenues and net income for 2025, accompanied by an approximately 7.1% increase in its common stock dividend and raised annual earnings guidance. This performance reflects ongoing growth from acquisitions, such as the Rancho Mission Viejo Portfolio in California, and highlights management’s confidence in Regency’s core business despite operating cost and debt-related pressures. Next, we'll explore how Regency's...

Designer Brands Inc. ( NYSE:DBI ) shareholders will doubtless be very grateful to see the share price up 37% in the...

Rogers, fresh off its third quarter earnings report, updated investors with new guidance for the upcoming quarter. The company projects slight year-over-year sales growth but a sequential drop, along with earnings per share expected to be modest at best. See our latest analysis for Rogers. Following the latest results and fresh guidance, Rogers’ share price has bounced 20.3% over the past three months. However, its one-year total shareholder return remains down 24.6%. Recent volatility likely...

Vaxcyte (PCVX) just wrapped up a busy week, announcing upbeat final results from its VAX-24 infant Phase 2 trial, key pipeline milestones, a major manufacturing deal, and a new commercial leadership hire. See our latest analysis for Vaxcyte. Vaxcyte’s share price has been on a rollercoaster this year, with recent momentum picking up after the strong VAX-24 trial data and major new manufacturing deal. Despite a tough year-to-date share price return of -49.9% and a one-year total shareholder...

Akamai Technologies (AKAM) just reported strong third quarter earnings growth and shared updated revenue guidance for both the upcoming quarter and the full year. In addition, the company announced its new Inference Cloud platform in partnership with NVIDIA. See our latest analysis for Akamai Technologies. Despite the upbeat earnings and Akamai’s ambitious new AI initiative with NVIDIA, the stock’s momentum has cooled this year. Akamai Technologies currently trades at $73.00, and the total...

The Acorn Energy, Inc. ( NASDAQ:ACFN ) share price has fared very poorly over the last month, falling by a substantial...

Anyone interested in Standex International Corporation ( NYSE:SXI ) should probably be aware that the VP, CFO...

At the recent Veeva Commercial Summit in Spain, Veeva Systems announced that more than 100 biotech organizations across 60 companies have adopted its Veeva Basics platform to standardize clinical, regulatory, and quality operations, with plans to release two new applications, Veeva LIMS Basics and Veeva PromoMats Basics, in early 2026 and further enhancements to follow. This strong uptake highlights how Veeva’s Vault Platform is enabling rapid deployment and scalability for biotechs aiming...

Kulicke and Soffa Industries (KLIC) is navigating a leadership change as Dr. Fusen Chen announced his retirement from CEO, President, and Board positions, effective December 1, 2025, for health reasons. Lester Wong steps in as Interim CEO, and a full search for a permanent successor is now underway. See our latest analysis for Kulicke and Soffa Industries. Kulicke and Soffa Industries’ recent leadership news arrived as the company’s share price has faced challenges, down 18.3% year-to-date,...

The Morning Bull - US Market Morning Update Friday, Nov, 7 2025 US stock futures are pointing higher ahead of the opening bell, as investors digest fresh signals that the job market may be losing steam. The closely watched yield on the 10-year US Treasury note dropped to 4.08% after reports showed layoffs surged to a two-decade high in October. In plain terms, this means the Federal Reserve could be more likely to cut interest rates soon, making borrowing a bit easier for families and...

Even though APi Group Corporation's ( NYSE:APG ) recent earnings release was robust, the market didn't seem to notice...

Babcock & Wilcox Enterprises, Inc. ( NYSE:BW ) insiders who purchased shares in the last 12 months were richly rewarded...

Following a Citi upgrade from Neutral to Buy, Kirby (KEX) shares have gained momentum as investors react to its strong third quarter results and its growing role in the AI-powered data center sector. See our latest analysis for Kirby. Kirby's latest quarter capped a remarkable month, with a 30% share price return signaling revived optimism among investors after its earnings update and recent buyback activity. The stock’s momentum is beginning to build again, though its 1-year total...

Investors were disappointed by Trinity Industries, Inc.'s ( NYSE:TRN ) latest earnings release. We did some analysis...

In the past week, Innospec Inc. reported third quarter 2025 results showing declines in both revenue and earnings, announced a semi-annual dividend of US$0.87 per share, and completed a share repurchase of 246,528 shares for US$22.2 million under its March 2025 buyback authorization. Despite the capital return initiatives, softer earnings and mixed analyst sentiment suggest investor focus remains on the company's operational challenges and future growth prospects. We'll examine how the...